Revelstoke Capital Partners
Revelstoke Capital Partners is a healthcare-focused private equity firm founded in 2013 that invests $50M-$500M of equity per platform in healthcare services, technology, and wellness companies, managing approximately $6.8 billion in AUM through its in-house Portfolio Transformation Group.
- Company typePrivate
- Founded2013
- HeadquartersDenver, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Revelstoke Capital Partners does
Revelstoke Capital Partners is a healthcare-focused private equity firm founded in 2013 and headquartered in Denver, Colorado, that invests $50 million to $500 million of equity per platform in healthcare services, healthcare technology, and health and wellness companies. The firm targets fragmented healthcare sub-sectors including behavioral health, home health and hospice, outpatient physical therapy, physician practice management, rural healthcare, ophthalmology, renal care, infusion therapy, medical aesthetics, veterinary services, and managed IT/cybersecurity for regulated industries. As of 2026, Revelstoke manages approximately $6.8 billion in assets under management across multiple fund vehicles (including RCP Funds I, II, III and EPIC funds), has completed 208 acquisitions since inception (176 add-ons), and employs 48 professionals. The firm earned a passive minority investment from Bonaccord Capital Partners (a P10, Inc. subsidiary) in October 2023.
The firm's core differentiator is its in-house Portfolio Transformation Group (PTG), an operating platform with six functional verticals: Strategy & Operations, Strategic Partnerships & Procurement, Technology, Talent, Responsible Investment, and Capital Markets. The PTG provides portfolio companies with dedicated operating resources analogous to a consulting function embedded within the sponsor, supplemented by senior technology and AI/Data Science leadership. Notable proprietary/portfolio-company technology assets include MediQuant's DataArk (enterprise healthcare data archive and interoperability platform), HealthAxis's AxisCore (cloud-enabled core payer administration platform), and Vi Labs (enterprise AI platform with predictive analytics, generative AI, and AI agents serving 100+ healthcare customers, 190M+ lives, and generating $2B+ in claimed value). In June 2026, Revelstoke formally launched the Revelstoke Frontier initiative to accelerate AI and automation adoption across the firm and portfolio.
Revelstoke generates revenue through management fees and carried interest on its private equity funds, with funds distributed exclusively to qualified institutional investors via private placement. Deal sourcing combines a research-driven thematic approach with direct outreach to founders, physician-leaders, and management teams. The firm is privately held, headquartered at 260 North Josephine Street, Suite 500, Denver, and is led by Founder & Managing Partner Simon Bachleda, Managing Partner Russell Cassella, and a broader partnership including Andrew Welch, Anthony Hayes, Michael Nutting, Samantha Gordon Webb (Head of PTG), and Greg Pupo (Partner, Investor Relations).
Revelstoke Capital Partners firmographics
Firmographics- Name
- Revelstoke Capital Partners
- Legal name
- Revelstoke Capital Management LLC
- Website
- https://revelstokecapital.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Revelstoke Capital Partners is a healthcare-focused private equity firm founded in 2013 that invests $50M-$500M of equity per platform in healthcare services, technology, and wellness companies, managing approximately $6.8 billion in AUM through its in-house Portfolio Transformation Group.
- Ownership category
- akta.pro rank
Revelstoke Capital Partners industry classification
Industry- Product category
- Healthcare Private Equity
- NAICS
- Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399), Other Investment Pools and Funds (5259)
- SIC
- Investment Advice (6282), Finance Services (6199)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
- akta.pro secondary industry
- Recapitalizations & Liability Management (Tender/Buybacks, Refinancing) (FSAHACAI)
Keywords
Where Revelstoke Capital Partners is headquartered
LocationHeadquarters
- HQ city
- Denver
- HQ country
- United States
- HQ region
- North America
Offices8 records
Markets served
Revelstoke Capital Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Revenue model
- Private Equity Fund Management: Revenues generated through management fees and carried interest (performance fees) from managing private equity funds focused on healthcare services, healthcare technology, and health and wellness. The firm manages approximately $6.8 billion in assets under management across multiple fund vehicles.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Private equity fund investment — terms not publicly disclosed |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Revelstoke Capital Partners product offering
Product offeringCore offering
Revelstoke Capital Partners is a healthcare-focused private equity firm that invests in healthcare services, healthcare technology, and health and wellness companies. The firm manages approximately $6.8 billion in assets under management across multiple fund vehicles (RCP Funds I, II, III and EPIC funds), deploying equity investments ranging from $50 million to $500 million per platform. The firm supplements its capital with operational support via an in-house Portfolio Transformation Group (PTG) that provides strategy, operations, finance, technology, talent, and capital markets expertise to portfolio companies.
Product overview
Revelstoke Capital Partners is a healthcare-focused private equity firm that invests in healthcare services, healthcare technology, and health and wellness companies. Rather than offering a unified software product, the firm provides investment capital and operational expertise through its Portfolio Transformation Group (PTG). The firm's portfolio includes companies like Vi Labs (AI-powered patient platform), along with healthcare services across behavioral health, veterinary, medical aesthetics, home health, and other sectors. Revelstoke Frontier is an internal initiative launched in 2026 to accelerate AI and automation adoption across the firm and its portfolio.
Differentiator
Problem solved
Functional benefit
Brands
- Portfolio Transformation Group: In-house operating team providing strategy, operations, technology, talent, responsible investment, and capital markets expertise to portfolio companies
- Revelstoke Frontier
Products and services
- Revelstoke Capital Partners Private Equity Funds
- Portfolio Transformation Group (PTG)
Quantifiable outcome
- 208 total acquisitions completed since inception in 2013
- +4 more outcomes
Companies that use Revelstoke Capital Partners
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles2 records
Revelstoke Capital Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature4 records
Revelstoke Capital Partners partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered supporting.
- Guggenheim Securities, LLCsupportingGuggenheim Securities, LLC served as financial advisor to Revelstoke Capital Partners in the recapitalization of AOM Infusion in April 2025.
- Houlihan LokeysupportingHoulihan Lokey served as financial advisor to Revelstoke Capital Partners in the recapitalization of AOM Infusion in April 2025.
- McGuireWoods LLPsupportingMcGuireWoods LLP served as legal counsel to Revelstoke Capital Partners in the recapitalization of AOM Infusion in April 2025. McGuireWoods also advised Revelstoke and The Care Team on the acquisition of Traditions Health hospice and palliative care operations.
- Jefferies LLCsupportingJefferies LLC served as financial advisor to AOM Infusion in its recapitalization with Revelstoke in April 2025.
- Moelis & CompanysupportingMoelis & Company served as financial advisor to AOM Infusion in its recapitalization with Revelstoke in April 2025.
- Q AdvisorssupportingQ Advisors acted as financial advisor to Revelstoke Capital Partners in the strategic investment in Omega Systems in January 2025.
- Harris WilliamssupportingHarris Williams served as financial advisor to Omega Systems in the strategic investment by Revelstoke Capital Partners in January 2025.
- Paul HastingssupportingPaul Hastings served as legal counsel to Omega Systems in the strategic investment by Revelstoke Capital Partners in January 2025.
- StoutsupportingStout served as exclusive financial advisor to NAKEDMD in Revelstoke's growth investment in November 2024.
- Winston & Strawn LLPsupportingWinston & Strawn acted as legal counsel to Revelstoke in the NAKEDMD investment. Winston & Strawn has served as legal advisor on multiple Revelstoke transactions.
- Kirkland & EllissupportingKirkland & Ellis served as legal advisor to both Revelstoke Capital Partners and Bonaccord Capital Partners in the October 2023 minority investment transaction.
Scale indicators11 records
Recent moves7 records
Expansion highlights6 records
Revelstoke Capital Partners competitors and assessment
Company assessmentDirect peers
- Linden Capital Partners: Chicago-based private equity firm exclusively focused on the healthcare industry across services, products, and distribution. Most directly comparable to Revelstoke given its healthcare-only thesis, middle-market platform orientation, and focus on management-led buyouts.
- Welsh, Carson, Anderson & Stowe: Healthcare-focused private equity firm with a long-standing, dedicated healthcare practice investing across services, technology, and information businesses. Directly comparable to Revelstoke on healthcare specialization and middle-to-upper-middle-market platform investments.
- New Mountain Capital: Growth-oriented private equity firm with a deep healthcare franchise spanning services, technology, and information sectors. Comparable to Revelstoke in its healthcare concentration and operating-value-creation orientation, though typically investing at larger check sizes.
- Avista Capital Partners: Healthcare-focused middle-market private equity firm investing in healthcare services, pharmaceutical services, and healthcare technology. Directly comparable on sector focus and middle-market platform thesis.
- KSL Capital Partners: Denver-based private equity firm with a dedicated healthcare and travel-leisure practice and a similar in-house operating-team model. Comparable to Revelstoke on geography, middle-market healthcare focus, and operational value creation approach.
- H.I.G. Capital: Global alternative investment firm with a healthcare-focused middle-market practice executing platform and add-on investments. Comparable to Revelstoke on middle-market healthcare services investing and bolt-on acquisition strategy.
Broad incumbents
- TPG Capital: Large, diversified alternative asset manager with a dedicated TPG Healthcare practice. Comparable as a competing healthcare-focused capital provider but operates at materially larger AUM and broader sector mandate than Revelstoke.
- Warburg Pincus: Global growth-oriented private equity firm with a long-standing healthcare franchise. Comparable on healthcare services and technology investing, but at substantially larger scale and with broader geographic mandate than Revelstoke.
Emerging players
- Cimarron Healthcare Capital: Healthcare-focused private equity firm pursuing lower-middle-market healthcare services and technology platforms. Comparable thesis to Revelstoke but operates at smaller deal sizes and earlier stage.
Others
- Bonaccord Capital Partners: Subsidiary of P10, Inc. (NYSE: PX) that made a passive minority investment in Revelstoke in October 2023. Not a direct competitor but adjacent — provides capital to mid-sized alternative asset managers like Revelstoke and represents a strategic capital partner rather than a peer manager.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Revelstoke Capital Partners social profiles
Digital presenceRevelstoke Capital Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Revelstoke Capital Partners leadership team
Management profileNumber of profiles
Profiles9 records
Revelstoke Capital Partners funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Revelstoke Capital Partners M&A and investment
M&A and investmentM&A7 records
Investments18 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Revelstoke Capital Partners
What does Revelstoke Capital Partners do?
Revelstoke Capital Partners is a healthcare-focused private equity firm that invests in healthcare services, healthcare technology, and health and wellness companies. The firm manages approximately $6.8 billion in assets under management across multiple fund vehicles (RCP Funds I, II, III and EPIC funds), deploying equity investments ranging from $50 million to $500 million per platform. The firm supplements its capital with operational support via an in-house Portfolio Transformation Group (PTG) that provides strategy, operations, finance, technology, talent, and capital markets expertise to portfolio companies.
Is Revelstoke Capital Partners a public or private company?
Revelstoke Capital Partners is a private company. It is classified as management employee owned and is currently operating.
When was Revelstoke Capital Partners founded?
Revelstoke Capital Partners was founded in 2013. It employs 51 to 100 people.
Where is Revelstoke Capital Partners based?
Revelstoke Capital Partners is headquartered in Denver, United States, in the North America region.
How does Revelstoke Capital Partners make money?
One revenue line is on record: private Equity Fund Management.
Who are Revelstoke Capital Partners's main competitors?
Direct peers on record are Linden Capital Partners, Welsh, Carson, Anderson & Stowe, New Mountain Capital, Avista Capital Partners, KSL Capital Partners and H.I.G. Capital. Broad incumbents are TPG Capital and Warburg Pincus. Cimarron Healthcare Capital is listed as an emerging player. Bonaccord Capital Partners is listed as an others.
Does Revelstoke Capital Partners have an API?
No public API is recorded for Revelstoke Capital Partners.
What industry is Revelstoke Capital Partners in?
Revelstoke Capital Partners's product category is Healthcare Private Equity. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSAHACAI, Recapitalizations & Liability Management (Tender/Buybacks, Refinancing). Its NAICS code is 523940 and its SIC code is 6282.